Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization
Sign Up to like & getrecommendations! Published in 2022 at "Theranostics"
DOI: 10.7150/thno.65098
Abstract: Rationale: Corneal neovascularization (CoNV) is a severe complication of various types of corneal diseases, that leads to permanent visual impairment. Current treatments for CoNV, such as steroids or anti-vascular endothelial growth factor agents, are argued… read more here.
Keywords: topical application; oxozeaenol; inhibitor; corneal neovascularization ... See more keywords